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Tissue morcellation during laparoscopic hysterectomy carries the risk of spreading cells from unsuspected malignancy. Contained
morcellation inside a bag is supposed to minimize this risk. The present study evaluated routine use of in-bag morcellation during
laparoscopic hysterectomy in a consecutive patient cohort (𝑛 = 49). The system used was More-Cell-Safe (A.M.I. Austria). Median
age was 47 (35 to 76) years and BMI 25.1 (18.8 to 39.8). Indications for hysterectomy were fibroids (71.4%), adenomyosis (16.3%),
prolapse (8.2%), and bleeding disorders (4.1%). 48 (98%) patients underwent supracervical hysterectomy and 1 (2%) underwent
total hysterectomy. No unsuspected malignancy occurred. Median weight of extirpated tissue was 195 g (18 to 1110). Residual tissue
and/or fluid in the bag amounted to 29 g (0 to 291). Median overall duration of surgeries was 100.5min, andmedian time associated
with the use of the bag was 10min (5 to 28), significantly correlated with uterine volume (𝑝 = 0.0094) and specimen weight
(𝑝 = 0.0002), but not with patient’s BMI (𝑝 = 0.6970). Technical success rate for contained morcellation was 93.9%. Peritoneal
washings after contained morcellation were all negative for malignant or smooth muscle cells.
1. Introduction
Laparoscopic hysterectomy requires special techniques in
order to remove the uterine specimen from the peritoneal
cavity despite small incisions. In case of supracervical hys-
terectomy, themain alternative to salvage laparotomy consists
in tissue morcellation, which may also become necessary for
total hysterectomy specimens when they are too large for
being pulled through the vagina entirely. Since 1993, method
of choice for tissuemorcellation has been powermorcellation
[1], which came under scrutiny after strong and repeated
warnings by the FDA in 2014 [2, 3], indicating the risk for
spreading malignant cells during the procedure originating
from unsuspected sarcoma mistaken for benign fibroids.
There is an ongoing debate on incidence and significance
of the phenomenon, withwide ranges of reported frequencies
between 0.02–0.25% referring to unsuspected leiomyosar-
coma and 0.13–0.47% to uterine malignancies overall [4–6].
But beside malignant processes, so-called parasitic leiomy-
oma or peritoneal adenomyosis has been reported as a result
of tissue dissemination as well [7–9].
Regardless of the dispute on incidence numbers, interna-
tional gynecological societies strongly recommend thorough
patient information on the potential risks and consent before
considering morcellation [4, 5, 10]. Beyond counseling, risk
stratification might improve patient selection, but despite
upcoming recommendations [4] valid concepts are missing
so far.
Another strategy to optimize patient safety, simulta-
neously maintaining the proven advantages of minimal
invasive hysterectomy [11, 12], would consist in improving
surgical techniques of morcellation. A promising approach
could be contained morcellation inside a bag in order
to prevent spilling of uterine tissue or cells [13, 14]. In
this regard, we recently introduced a new system for in-
bag morcellation, which proved feasibility and a preventive
effect in both experimental and clinical pilot settings [15,
16].
The aim of the present work was to report our continued
experience using the new system in clinical routine applica-
tion during laparoscopic hysterectomy.
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Figure 1: More-Cell-Safe bag (A.M.I. Austria) for contained power
morcellation: material polyurethane, feed sizes of 340 × 250mm,
capacity 2.5 liters; large opening of 160mm for specimen placement
and morcellator access and small tubular opening for optic trocar
access.
2. Materials and Methods
2.1. Patients. Experiences with contained morcellation dur-
ing laparoscopic hysterectomy in 𝑛 = 49 consecutive patients
were retrospectively analysed in this observational cohort
study after obtaining CE approval. Informed consent was
obtained from all patients. Counseling included information
on the surgical techniques, alternatives, risks, and benefits of
laparoscopic hysterectomy as well as on power morcellation
risks. Possible spread of undetected malignancy was quoted
according to the statement of the DGGG [5].
2.2. Operative Procedure. According to the description in
our preceding pilot study, the procedure started with total
or supracervical laparoscopic hysterectomy. A multiport
approach was used with a 11mm umbilical trocar for optic
(0∘), suprapubic, and two lateral 6mm trocars. After com-
pleting the hysterectomy, the More-Cell-Safe system (A.M.I.
Austria) for contained power morcellation (Figure 1) was
introduced into the peritoneal cavity via either a 12mm
disposable plastic sheath (MCS-Port, A.M.I. Austria) or a
13mm reusable metal trocar (Karl Storz, Germany). The
polyurethane bag (More-Cell Bag, A.M.I. Austria) has feed
sizes of 340 × 250mm and a capacity of 2.5 liters. It has two
openingsmeasuring 160 and 16mm.The large opening serves
as a specimen placement and morcellator access suprapu-
bically. The small opening allows optical trocar insertion at
the umbilical site. The outer part of the tubular bag opening
is everted to protect it from contamination by spread cells
during use. In order to allow the bag to be introduced through
the suprapubic trocar, it is delivered folded into a sleeve,
that has to be stripped while inserting into the bag. First-
generation bags were rolled instead of being folded. These
were applied in 11 cases. Second-generation bags are folded
allowing self-opening of the large mouth of the bag into the
peritoneal cavity after insertion. Those were applied in all
consecutive cases (12–49).
An 11mm sleeve (Visi-Shield) covers the optic in order to
prevent cell contamination during in-bag use. The shield is
disposed at the end of morcellation before further use of the
optic inside the peritoneal cavity.
After inserting the bag into the peritoneal cavity, the spec-
imenwas placed into the bagwith the help of grasping forceps
using the lateral trocars. For larger specimen handling, a third
instrument was applied using the suprapubic access port.
After positioning the specimen, the large mouth of the bag
was pulled out suprapubically with help of a retrieval thread
and simultaneously the respective port removed.The tubular
bag opening was now exteriorized through the umbilical
access while removing the 11mm optic trocar.
At this point, the umbilical fascia was enlarged in order
to allow entering the larger trocar into the bag. Trocar
size is determined by the Visi-Shield diameter requiring at
least 12mm trocar to allow its passage and adequate gas
flow between shield and trocar wall. Fascia enlargement was
performed bluntly digitally in the first 9 cases and with
sharp cutting with scissors under external vision in the 40
consecutive cases. For optic trocar access to the bag, a 12mm
blunt disposable trocar (Versaport, CovidienMedtronic) was
used in the first 17 patients, and in all consecutive patients
a 13mm reusable blunt tipped metal trocar was used (Karl
Storz, Germany). A pseudopneumoperitoneum was now
established inflating the bag via the umbilical trocar and the
optic reentered covered by its protective shield.Themorcella-
tor (Rotocut G1, Karl Storz Germany, 12 or 15mm according
to the surgeons preference) was then entered bluntly into
the bag at its suprapubic opening and electromorcellation
started in a contained, but otherwise unchanged technique
(Figure 2). In case of total hysterectomy, vaginal closure was
performed prior to morcellation.
After completion, both morcellator and optic were with-
drawn from the bag. Visi-Shield and optic trocar were dis-
posed, the everted tubular part of the bag was unrolled, and
the bag was securely closed by two knots. Now, the bag was
removed by manually pulling it towards the suprapubic site.
For continued laparoscopy, the previously removed 11mm
optic trocar and the optic without shield was reinserted.
2.3. Parameter and Statistical Analysis. Patient baseline char-
acteristics were recorded including age, BMI, history of previ-
ous surgery, and preoperative findings including transvaginal
ultrasound measurements and indication for surgery.
Procedural parameters were recorded as type of hys-
terectomy, eventual complementary surgery, and duration
of surgery, differentiated into overall procedure time, times
associated with the use of the bag, and morcellation time.
Overall resected tissue weight was calculated from measured
weights of morcellated specimen and residual tissue or fluid
inside the bag after removal.
Complications were recorded as intra- or postoperative
ones, and duration of hospital stay was registered from
surgery to discharge.
Feasibility of in-bag morcellation was determined as
intraoperative technical success rate defined as successfully
completed containedmorcellation procedure including proof
of bag integrity after removal by visual inspection and
blue stain fluid filling. Additional qualitative parameter was
bag handling, adequate pseudopneumoperitoneum, in-bag
visualization, and morcellation performance as assessed by
the surgeon.
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Figure 2: (a/b) Technique of contained in-bag power morcellation of a supracervical hysterectomy specimen using More-Cell-Safe (A.M.I.,
Austria).
Table 1: Indications for hysterectomy.
Symptomatic fibroids 35 (71.4%)
Adenomyosis 8 (16.3%)
Prolapse (combined with cervicosacropexy) 4 (8.2%)
Bleeding disorders (dehiscent cesarean scar) 2 (4.1%)
Table 2: Patient and specimen characteristics.
Median Range
Patient age 47 years 35–76
BMI 25.1 18.8–39.8
Uterine volume (ultrasound) 350 cm3 36–2016
Weight of extirpated tissue 195 g 18–1110
Weight of morcellated tissue 170 g 18–819
Residual tissue/fluid in the bag 29 g 0–291
Postoperative histology was registered and compared to
preoperative findings. In order to evaluate potential cell
spillage from morcellated tissue, cytology was analysed for
the presence of smoothmuscle cells fromperitoneal washings
taken at the end of the surgical procedure.
Statistical analyses were performed using GraphPad soft-
ware with descriptive calculations of median and minimum
to maximum range, mean, and 95% confidence interval. Lin-
ear regression analysis was performed to describe influence
factors on bag associated duration of surgery.
3. Results
3.1. Patient Baseline Characteristics (Tables 1 and 2). Median
age was 47, ranging from 35 to 76 (mean 48.3; 95% CI
45.93–50.64). Patient BMI ranged from 18.8 to 39.8 with a
median at 25.1 (mean 26.7; 95% CI 25.04–28.41).
Only 24 (49%) patients had no previous abdominal
surgery. The others had undergone one or more previous
surgeries, among these laparoscopic interventions in 18
(36.7%) cases (myomectomy, endometriosis, ovarian cys-
tectomy or ovariectomy, ectopic pregnancy, tubal ligation,
cholecystectomy, and sigma resection), cesarean sections
in 10 (20.4%) cases, and open surgery in 8 (16.3%) cases
(endometriosis, appendectomy, cholecystectomy, and adhe-
siolysis for bowel obstruction).
Table 3: Duration of surgery, morcellation, and bag application.
Median Range
Overall duration of surgery 100.5min 55–239
Overall time of bag use (in/out) 19.5min 8–82
Morcellation time 9min 2–54
Total time associated with bag use 10min 5–28
Bag preparation time before morcellation 8.5min 4–26
Bag removal time 1min 0–8
Indications for hysterectomy were symptomatic fibroids
in 35 (71.4%) cases (7 isolated, 28 multiple myoma), ade-
nomyosis in 8 (16.3%) cases, prolapse in 4 (8.2%) cases
(combined with cervicosacropexy), and bleeding disorders
in the presence of dehiscent cesarean uterotomy in 2 (4.1%)
cases.Three (8.6%) of the 35 myoma patients were pretreated
with ulipristal acetate.
Median uterine volume based on transvaginal ultrasound
measurement was 350 cm3 (range 36 to 2016;mean 515.2; 95%
CI 390.05–640.28).
3.2. Procedural Parameter (Table 3). Scheduled laparoscopic
hysterectomy was performed in all patients without intra-
operative complications. 48 (98%) underwent supracervical
hysterectomy and 1 (2%) underwent total hysterectomy.
All patients underwent additional interventions (46 salp-
ingectomy, 1 ovarian cyst removal, 4 endometriosis resection,
and 4 cervicosacropexy) besides hysterectomy, which were
however performed before in-bag morcellation in all cases
except one umbilical hernia repair. Remarkably, in 2 of the
three cases after previous laparoscopic myomectomy, there
were several parasitic myoma cases. All were removed with
unsuspicious histological results.
Median overall duration of surgeries was 100.5min (range
55 to 239; mean 110.4; 95% CI 97.45–123.38). The median
overall time frame of bag use from insertion to removal was
19.5min (range 8 to 82; mean 24.4; 95% CI 16.85–31.97).
Morcellation time ranged from 2 to 54min with a median of
9min (mean 12.1; 95%CI 7.15–17.12).The time associated with
the use of the bag (in total, before and after morcellation) was
10min (median; range 5 to 28; mean 12.3; 95% CI 9.23–15.31).
There was a significant correlation with uterine volume (𝑝 =
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Figure 3: Linear regression analysis showing bag associated time
during surgery significantly correlated with uterine volume (𝑝 =
0.0094) and specimen weight (𝑝 = 0.0002), but not with patients
BMI (𝑝 = 0.6970).
0.0094) and specimen weight (𝑝 = 0.0002), but not with
patient’s BMI (𝑝 = 0.6970) (Figure 3).
Inserting and preparation of the bag including specimen
placement until start of morcellation took 8.5min (median;
range 4 to 26; mean 11.0; 95% CI 8.33–13.67). Removal of the
bag aftermorcellationwas performed in 1min (median; range
0 to 8; mean 1.3; 95% CI 0.53–2.01).
Median overall weight of extirpated tissue was 195 g
ranging from 18 to 1110 (mean 269.7; 95% CI 204.20–335.27).
Table 4: Technical feasibility of in-bag morcellation.
Successful and bag intact 46 (93.9%)
Bag defect 3 (6.1%)
Findings in cases of defect
bag
(i) 3mm tear at tubular part due to
shearing by the umbilical trocar
(too small fascia incision)
(ii) Bag ruptured during forced
extraction (calcified myoma 50mm
remaining in the bag)
(iii) Bag ruptured during forced
extraction (residual piece of myoma
30mm ignored)
From this, morcellated tissues had a median weight of 170 g
(range 18 to 819; mean 250; 95% CI 191.41–308.59). Residual
tissue and/or blood that remained in the bag and then
removed at the end of the procedure amounted to 29 g
(median; range 0 to 291; mean 47.8; 95% CI 15.60–80.10).
3.3. Clinical Complications and Duration of Hospital Stay.
There were no intraoperative clinical complications. Postop-
eratively, one patient developed a fever of unknown origin
butwas treated successfullywith antibiotics.Median duration
until discharge from the hospital was 3 days (range 2 to 11;
mean 3.3; 95% CI 2.91–3.66).
3.4. Feasibility of In-Bag Morcellation (Table 4). Contained
morcellation was performed successfully and intact bag after
removal in 46 of 49 cases resulted in a technical success rate
of 93.9%.
In 3 (6.1%) cases bags appeared not intact after the
procedure. One bag showed a 3mm tear at its tubular
part during postprocedural extracorporeal stain fluid filling
test. Pattern and localisation of the lesion as well as docu-
mented technical problems during umbilical trocar insertion
lead to the assumption of shearing by the trocar passing
through a too small fascia incision. A second bag was first
punctually damaged with the morcellator forceps before
morcellation, removed, and replaced by another bag, but
this finally ruptured during forced extraction with an inside
remaining calcified 5 cm myoma not passing through an
inadequate suprapubic incision. Comparably, the third bag,
which resulted in defect, ruptured during forced extraction
because of an ignored residual piece of myoma of 30 × 15 ×
15mm.
Despite successful procedures, handling difficulties
occurred in 8 (16.3%) cases. In two cases, the surgeon
decided to remove and replace the initial bags because they
were twisted after insertion to the peritoneal cavity and
specimen placement was not possible. In both cases, first-
generation bags were applied; procedures were successful
during second attempt. In a third case, the bag was perforated
with the umbilical trocar during insertion. The perforation
occurred before morcellation and was immediately detected
when the optic was introduced, showing the peritoneal cavity
outside the bag. The bag was removed and replaced. The
second attempt was then completely successful after having
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enlarged the umbilical fascia opening. A fourth case also
required change of the bag because of an apparent defect at
the tubular segment after pulling it through the umbilical
trocar before even starting the in-bag procedure. In the fifth
and sixth case with handling difficulties, several attempts of
optic trocar insertion into the bag were necessary and only
successful after adequately enlarging the fascia incision. In
two further difficult cases, it was the surgeon who forgot
to strip the sleeve from the bag during initial insertion,
which made complete removal and reinsertion of the bags
necessary.
There were no difficulties regarding pseudopneumoperi-
toneum and during actual morcellation. Once the optic tro-
car was adequately positioned, a pseudopneumoperitoneum
could be established regularly in all cases.This applied as well
for the defect bag presumably damaged by the optic trocar
prior to morcellation. In-bag visualization was not impaired
and allowed regular power morcellation in all cases. Median
morcellation time was 9min (range 2 to 54; mean 12.1; 95%
CI 7.15 to 17.12).
3.5. Postoperative Histology and Results of Peritoneal Wash-
ings. Fibroids were found in 35 cases, sometimes associated
with adenomyosis. Adenomyosis alone was described in 11
cases. In three cases, specimen did not show pathology except
dehiscence of a former cesarean uterotomy scar in 2 instances.
Histology confirmed the clinical suspicion in 45 (91.8%)
cases. In 1 case an adenomyoma had been mistaken for a
fibroid, and in 3 (6.1%) cases histology revealed a fibroid
(1) and adenomyosis (2) sonographically were not detected.
Cases of unsuspected malignancies did not occur.
Cytology from the peritoneal washings showed mesothe-
lial cells and/or leucocytes, erythrocytes, andmacrophages in
all examined cases but was negative for malignant or smooth
muscle cells each time.
4. Discussion
Technical feasibility of in-bag power morcellation using the
setting here applied had previously been shown in a small
pilot series [16]. Data from the present collection of 49
consecutive patients were gathered in order to prospectively
examine suitability for use in clinical routine. In fact, enclosed
patients represent an unselected cohort of women at varying
age, BMI, medical history, and indications for hysterectomy.
Technical success was achieved under these conditions in
93.9%, confirming our pilot results. The absence of smooth
muscle cells in all peritoneal washings suggests effective
prevention against spilling of cells from themorcellated tissue
[15, 17].
The occurrence of three failure cases (6.1%) indicates a
remaining risk potential that needs being addressed during
informed consent. Analysis of the cases reveals the surgeon’s
impact on outcome. Restricting the incision of the fascia
too much at the umbilical trocar site was not only the main
reason for handling difficulties during bag preparation, but
also responsible for one of the failure cases with a trocar
associated shear lesion of the bag. Bag ruptures occurred only
as a consequence of forced extraction in the presence of larger
in-bag residuals. Meticulous removal of morcellated tissue
from the bag and avoiding force during bag extraction will
make bag rupture less likely. In case of tissue remnants which
are resistant tomorcellation, such as a calcifiedmyoma in one
of our cases, adequate abdominal wall incision is mandatory.
Small residual tissue pieces and fluid in the bag, however,
do not interfere with appropriate extraction. In our series,
they were regularly noted with amedian weight of 29 g (range
0 to 291 g). Anapolski et al. [18] reported 12.1 g (range 7
to 19 g) from a pilot study using a different type of bag.
Saving time and effort to collect these fragments and rinse
the peritoneal cavity may be a positive side-effect of in-bag
versus uncontained morcellation.
Nevertheless, application of a bag system consumes time,
which was reported to prolong surgery by 20–30min as
compared to retrospective controls with uncontained mor-
cellation [14, 19, 20]. In the present study, median total time
associated with the bag use was only 10min, confirming
the positive experience from our pilot work [16]. It ranged
from 5 to 28min, which was significantly correlated with
uterine size, ranging from 18 to 1110 g (median 195 g). The
most time consuming stage was inserting the bag, placing
the specimen, and preparing for morcellation with a median
proportional time span of 8.5min versus only 1min to remove
the bag afterwards. Time specifications in different studies
must be compared with caution because of their correlation
with specimen sizes in the respective cohorts. Nevertheless,
two recent studies using different systems [18, 21] came
to slightly longer, but essentially comparable results with
10.5 and 12.5min preparation time for in-bag morcellation,
thus increasing acceptability for clinical routine.
In contrast to our pilot experiences [16], uterine size was
not limiting applicability of contained morcellation in this
series, though the largest specimen weighed 1110 g. Despite
the surgeon’s subjective impression, there was no statistically
detectable correlation of difficulties, measurable in procedure
duration, with patient’s BMI. Problems in handling occurred
with first-generation bags, which did not open properly.
This problem was solved by introducing differently folded
second-generation bags, providing easier access for specimen
placement. The importance of adequate umbilical fascia
incision has already been pointed out. Once, blunt trocar
access to the bag interior was successfully established, the
actual morcellation process was assessed unhindered and not
prolonged under the circumstances of the contained setting.
Technical alternatives consist in vaginal, single-site, or
manual open concepts for in-bag morcellation [22–26].
Vaginal access would have been possible for only one of
our patients undergoing total hysterectomy, while it was
not applicable for all others, operated upon supracervically.
Single-site techniques would require a major change of our
clinical routine but have to be taken into consideration, as
recently the FDA allowed marketing of a bag for contained
morcellation using single-site access [27]. Manual in-bag
morcellation requires appropriate incisions of the abdominal
wall and abandons power morcellation in favor of the scalpel
but represents a practicable alternative with the advantage of
direct external visual control.
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5. Conclusions
The technique presented here allows in-bag power morcella-
tion during laparoscopic hysterectomy in a usual multiport
approach with proven feasibility. Preventive effectiveness
against spilling from morcellated tissue is suggested by
reproducible results of negative peritoneal washings. The
promising single center data of this study will now need
confirmation in a prospective multicentric approach.
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